In8bio Capex To Operating Cash Flow vs Cash Per Share Analysis

INAB Stock

USD 0.29 0.01 4.67%

In8bio financial indicator trend analysis is infinitely more than just investigating In8bio Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether In8bio Inc is a good investment. Please check the relationship between In8bio Capex To Operating Cash Flow and its Cash Per Share accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Capex To Operating Cash Flow vs Cash Per Share

Capex To Operating Cash Flow vs Cash Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of In8bio Inc Capex To Operating Cash Flow account and Cash Per Share. At this time, the significance of the direction appears to have no relationship.

The correlation between In8bio's Capex To Operating Cash Flow and Cash Per Share is 0.09. Overlapping area represents the amount of variation of Capex To Operating Cash Flow that can explain the historical movement of Cash Per Share in the same time period over historical financial statements of In8bio Inc, assuming nothing else is changed. The correlation between historical values of In8bio's Capex To Operating Cash Flow and Cash Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Operating Cash Flow of In8bio Inc are associated (or correlated) with its Cash Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Per Share has no effect on the direction of Capex To Operating Cash Flow i.e., In8bio's Capex To Operating Cash Flow and Cash Per Share go up and down completely randomly.

Correlation Coefficient

0.09

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Capex To Operating Cash Flow

Cash Per Share

Most indicators from In8bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into In8bio Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Enterprise Value is expected to grow to about 39.9 M, whereas Selling General Administrative is forecasted to decline to about 7.8 M.

	2022	2023	2024	2025 (projected)
Reconciled Depreciation	1.1M	2.5M	2.9M	3.0M
Total Operating Expenses	28.5M	30.3M	34.9M	36.6M

Reconciled Depreciation Total Operating Expenses

In8bio fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Net Working Capital
Total Assets		0.88	0.99	0.88	0.78	-0.87	-0.84	0.6	0.97	0.81	0.37	0.4	0.97	-0.36	-0.36	0.83	0.77	-0.36	0.84	0.85	0.86	0.88	0.78	0.98	-0.39	0.95
Total Current Liabilities	0.88		0.8	0.83	0.9	-0.55	-0.93	0.82	0.73	0.93	0.39	0.37	0.73	-0.39	-0.39	0.91	0.91	-0.39	0.86	0.87	0.99	0.74	0.9	0.78	-0.38	0.69
Total Stockholder Equity	0.99	0.8		0.84	0.69	-0.94	-0.77	0.49	0.99	0.73	0.38	0.43	0.99	-0.34	-0.34	0.77	0.68	-0.34	0.78	0.8	0.77	0.86	0.7	1.0	-0.34	0.99
Net Tangible Assets	0.88	0.83	0.84		0.92	-0.66	-0.91	0.64	0.79	0.9	0.03	0.06	0.79	-0.59	-0.59	0.75	0.87	-0.59	0.86	0.96	0.86	0.98	0.93	0.83	-0.73	0.79
Property Plant And Equipment Net	0.78	0.9	0.69	0.92		-0.44	-0.95	0.81	0.62	0.99	0.16	0.16	0.62	-0.65	-0.65	0.78	0.92	-0.65	0.85	0.95	0.93	0.83	1.0	0.68	-0.61	0.59
Net Debt	-0.87	-0.55	-0.94	-0.66	-0.44		0.55	-0.23	-0.97	-0.5	-0.41	-0.48	-0.97	0.24	0.24	-0.58	-0.4	0.24	-0.59	-0.61	-0.5	-0.74	-0.45	-0.94	0.18	-0.98
Retained Earnings	-0.84	-0.93	-0.77	-0.91	-0.95	0.55		-0.7	-0.71	-0.96	-0.29	-0.28	-0.71	0.6	0.6	-0.89	-0.86	0.6	-0.78	-0.97	-0.92	-0.83	-0.97	-0.76	0.52	-0.68
Accounts Payable	0.6	0.82	0.49	0.64	0.81	-0.23	-0.7		0.4	0.82	0.22	0.21	0.4	-0.27	-0.27	0.61	0.86	-0.27	0.89	0.63	0.85	0.53	0.77	0.47	-0.36	0.37
Cash	0.97	0.73	0.99	0.79	0.62	-0.97	-0.71	0.4		0.66	0.39	0.44	1.0	-0.32	-0.32	0.73	0.59	-0.32	0.72	0.75	0.69	0.84	0.63	1.0	-0.3	1.0
Non Current Assets Total	0.81	0.93	0.73	0.9	0.99	-0.5	-0.96	0.82	0.66		0.3	0.3	0.66	-0.65	-0.65	0.82	0.89	-0.65	0.85	0.95	0.94	0.8	0.99	0.72	-0.5	0.63
Non Currrent Assets Other	0.37	0.39	0.38	0.03	0.16	-0.41	-0.29	0.22	0.39	0.3		0.99	0.39	-0.19	-0.19	0.45	-0.01	-0.19	0.12	0.19	0.25	-0.03	0.17	0.37	0.65	0.35
Other Assets	0.4	0.37	0.43	0.06	0.16	-0.48	-0.28	0.21	0.44	0.3	0.99		0.44	-0.22	-0.22	0.44	-0.02	-0.22	0.14	0.21	0.23	0.01	0.16	0.42	0.63	0.4
Cash And Short Term Investments	0.97	0.73	0.99	0.79	0.62	-0.97	-0.71	0.4	1.0	0.66	0.39	0.44		-0.32	-0.32	0.73	0.59	-0.32	0.72	0.75	0.69	0.84	0.63	1.0	-0.3	1.0
Net Receivables	-0.36	-0.39	-0.34	-0.59	-0.65	0.24	0.6	-0.27	-0.32	-0.65	-0.19	-0.22	-0.32		1.0	-0.45	-0.34	1.0	-0.28	-0.7	-0.38	-0.53	-0.68	-0.34	0.34	-0.31
Common Stock Total Equity	-0.36	-0.39	-0.34	-0.59	-0.65	0.24	0.6	-0.27	-0.32	-0.65	-0.19	-0.22	-0.32	1.0		-0.45	-0.34	1.0	-0.28	-0.7	-0.38	-0.53	-0.68	-0.34	0.34	-0.31
Common Stock Shares Outstanding	0.83	0.91	0.77	0.75	0.78	-0.58	-0.89	0.61	0.73	0.82	0.45	0.44	0.73	-0.45	-0.45		0.75	-0.45	0.69	0.84	0.86	0.69	0.8	0.77	-0.29	0.69
Non Current Liabilities Total	0.77	0.91	0.68	0.87	0.92	-0.4	-0.86	0.86	0.59	0.89	-0.01	-0.02	0.59	-0.34	-0.34	0.75		-0.34	0.92	0.84	0.96	0.8	0.9	0.66	-0.68	0.57
Inventory	-0.36	-0.39	-0.34	-0.59	-0.65	0.24	0.6	-0.27	-0.32	-0.65	-0.19	-0.22	-0.32	1.0	1.0	-0.45	-0.34		-0.28	-0.7	-0.38	-0.53	-0.68	-0.34	0.34	-0.31
Other Current Assets	0.84	0.86	0.78	0.86	0.85	-0.59	-0.78	0.89	0.72	0.85	0.12	0.14	0.72	-0.28	-0.28	0.69	0.92	-0.28		0.78	0.9	0.82	0.82	0.77	-0.57	0.7
Other Stockholder Equity	0.85	0.87	0.8	0.96	0.95	-0.61	-0.97	0.63	0.75	0.95	0.19	0.21	0.75	-0.7	-0.7	0.84	0.84	-0.7	0.78		0.88	0.91	0.97	0.79	-0.61	0.73
Total Liab	0.86	0.99	0.77	0.86	0.93	-0.5	-0.92	0.85	0.69	0.94	0.25	0.23	0.69	-0.38	-0.38	0.86	0.96	-0.38	0.9	0.88		0.78	0.92	0.75	-0.5	0.66
Net Invested Capital	0.88	0.74	0.86	0.98	0.83	-0.74	-0.83	0.53	0.84	0.8	-0.03	0.01	0.84	-0.53	-0.53	0.69	0.8	-0.53	0.82	0.91	0.78		0.84	0.87	-0.75	0.84
Property Plant And Equipment Gross	0.78	0.9	0.7	0.93	1.0	-0.45	-0.97	0.77	0.63	0.99	0.17	0.16	0.63	-0.68	-0.68	0.8	0.9	-0.68	0.82	0.97	0.92	0.84		0.68	-0.61	0.6
Total Current Assets	0.98	0.78	1.0	0.83	0.68	-0.94	-0.76	0.47	1.0	0.72	0.37	0.42	1.0	-0.34	-0.34	0.77	0.66	-0.34	0.77	0.79	0.75	0.87	0.68		-0.35	0.99
Capital Stock	-0.39	-0.38	-0.34	-0.73	-0.61	0.18	0.52	-0.36	-0.3	-0.5	0.65	0.63	-0.3	0.34	0.34	-0.29	-0.68	0.34	-0.57	-0.61	-0.5	-0.75	-0.61	-0.35		-0.32
Net Working Capital	0.95	0.69	0.99	0.79	0.59	-0.98	-0.68	0.37	1.0	0.63	0.35	0.4	1.0	-0.31	-0.31	0.69	0.57	-0.31	0.7	0.73	0.66	0.84	0.6	0.99	-0.32

Click cells to compare fundamentals

In8bio Account Relationship Matchups

In8bio fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	20.9M	42.2M	33.0M	33.7M	38.8M	25.1M
Total Current Liabilities	2.6M	2.3M	5.8M	5.4M	6.2M	3.1M
Total Stockholder Equity	18.3M	38.2M	22.7M	24.9M	28.7M	19.9M
Property Plant And Equipment Net	186K	2.8M	10.3M	8.6M	9.9M	10.4M
Net Debt	(17.8M)	(34.6M)	(12.3M)	(16.4M)	(14.8M)	(15.5M)
Retained Earnings	(18.0M)	(32.7M)	(61.2M)	(91.2M)	(82.1M)	(78.0M)
Accounts Payable	620K	395K	2.1M	924K	1.1M	918.3K
Cash	18.0M	37.0M	18.2M	21.3M	24.5M	18.3M
Non Current Assets Total	2.8M	3.2M	10.8M	9.1M	10.4M	11.0M
Non Currrent Assets Other	2.6M	158K	381K	511K	587.7K	687.7K
Cash And Short Term Investments	18.0M	37.0M	18.2M	21.3M	24.5M	18.3M
Liabilities And Stockholders Equity	20.9M	42.2M	33.0M	33.7M	38.8M	25.1M
Non Current Liabilities Total	17K	1.8M	4.5M	3.4M	3.9M	2.1M
Other Current Assets	150K	3.9M	7.9M	3.3M	3.8M	2.8M
Other Stockholder Equity	1.5M	70.9M	83.9M	116.2M	133.6M	140.3M
Total Liab	2.6M	4.0M	10.3M	8.8M	10.1M	5.2M
Net Invested Capital	(16.4M)	38.2M	22.7M	24.9M	28.7M	30.1M
Property Plant And Equipment Gross	186K	3.2M	10.3M	9.9M	11.3M	11.9M
Total Current Assets	18.1M	39.0M	22.2M	24.6M	28.3M	20.1M
Capital Stock	34.9M	2K	3K	4K	3.6K	3.4K
Net Working Capital	15.6M	36.7M	16.4M	19.2M	22.1M	17.0M
Other Current Liab	1.8M	609K	953K	3.0M	3.4M	3.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
V	Visa Class A
C	Citigroup

When determining whether In8bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of In8bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of In8bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on In8bio Inc Stock:

How To Invest In In8bio

Details

Is In8bio Stock a good investment?

Details

What is In8bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.74)

Return On Assets

(0.78)

Return On Equity

(1.80)

The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

In8bio Capex To Operating Cash Flow vs Cash Per Share Analysis

Capex To Operating Cash Flow vs Cash Per Share

Capex To Operating Cash Flow vs Cash Per Share Correlation Analysis

Correlation Coefficient

Capex To Operating Cash Flow

Cash Per Share

In8bio fundamental ratios Correlations

In8bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

In8bio fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Stockholder Equity
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Net Working Capital	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments

Net Working Capital	- 0.98	Net Debt
Property Plant And Equipment Gross	- 0.97	Retained Earnings
Other Stockholder Equity	- 0.97	Retained Earnings
Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Non Current Assets Total	- 0.96	Retained Earnings